Navigation Links
KV Pharmaceutical Reaches Agreement with U.S. Department of Justice
Date:2/25/2010

-K filed with the SEC on April 30, 2009, the Company's Form 8-K filed with the SEC on July 24, 2009, the Company's Form 8-K filed with the SEC on November 12, 2009 and the Company's Form 8-K filed with the SEC on February 25, 2010;
  • delays in returning, or failure to return, certain or many of the Company's approved products to market, including loss of market share as a result of the suspension of shipments, and related costs;
  • the ability to sell or license certain assets, and the terms of such transactions;
  • the possibility that default on one type or class of the Company's indebtedness could result in cross default under, and the acceleration of, the Company's other indebtedness;
  • the possibility that the failure to timely file the Company's Annual Report on Form 10-K for fiscal year 2009 with the SEC could result in the delisting of the Company's securities by the New York Stock Exchange; and
  • the risks detailed from time to time in the Company's filings with the SEC.

  • This discussion is not exhaustive, but is designed to highlight important factors that may impact the Company's forward-looking statements.  

    Because the factors referred to above, as well as the statements included elsewhere in this press release, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by the Company or on the Company's behalf, you
    '/>"/>

    SOURCE KV Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... and TORONTO , Aug. 27, 2015 ... today announced the issuance of a white paper on ... insulin spray product.  The white paper was presented to ... stockholders by Dr. James H. Anderson, Jr. , ... may be viewed online on the Generex website. ...
    (Date:8/27/2015)... pharmaceutical and medical device companies and leading law firms will ... on Oct. 20, discussing issues surrounding regulatory compliance, ... Litigation Conferences has announced. To learn more ... The program is co-chaired by Megan Grossman ... Hart Yeary of Dechert LLP. Topics include: ...
    (Date:8/27/2015)... -- Mytrus, a technology and services company revolutionizing clinical trials, announced today ... received approval for use by Britain,s ... time e-Consent technology will be used in a trial ... Mytrus was also the first electronic informed consent technology ... U.S. Food and Drug Administration in 2011. It has ...
    Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
    ... U L URUI nc. (NYSE Amex: ... an abbreviated 510(k) application with the U.S. Food and Drug ... and mitigation of pain. The principal data supporting ... to Acquacel® Ag in skin graft donor sites. This amended ...
    ... 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... "Company"), a leading China-based pharmaceutical and biotechnology ... that its wholly-owned contract research subsidiary, Shanghai ... agreement with Shenogen Pharma Group to develop ...
    Cached Medicine Technology:ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group 2
    (Date:8/27/2015)... ... 2015 , ... Keck Graduate Institute (KGI), School of Pharmacy celebrated its Second ... formal ceremony recognizing them as members of the 2nd class of the KGI School ... dedication to clinical service and patient care, the White Coat Ceremony is held every ...
    (Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of 10 ... and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to assist ... a $7,500 scholarship to assist in his goal of becoming a foreign diplomat with ...
    (Date:8/27/2015)... ... August 27, 2015 , ... According to ... treat a patient with hemophilia is $175,000. Hemophilia is an inherited, life-long condition ... treatment. The RMHBDA exists to help raise funds for patients suffering from bleeding ...
    (Date:8/27/2015)... Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... most recent World Conference on Abdominal Wall Hernia Surgery involved many conversations between hernia ... mesh options out there, the article notes that many different experts have different ideas ...
    (Date:8/27/2015)... ... , ... In an article published July 30th by the New ... Orleans, highlighting a security firm that is tasked with providing supplemental protection. Called the ... worked with the city to provide private security when it is needed in a ...
    Breaking Medicine News(10 mins):Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2
    ... among people exposed to toxic gases from the Union Carbide ... the Bhopal gas tragedy Sunday demanded free treatment of the ... government. ,The Bhopal tragedy occurred on the night ... methyl iso-cyanate (MIC) spewed out of the pesticide plant, in ...
    ... serious and progressive medical condition, has been and remains ... for kidney function, people who are at high risk ... those at increased risk for potentially undiagnosed CKD, a ... Cornell Medical College and the University of North Carolina ...
    ... with the involvement of social services in the case of Connor ... three times the average for his age. ,The boy ... not undergo a sea change. He holds a record of breaking ... ,Connor’s mother and grandmother are expected to attend a child ...
    ... most common treatments for prostate cancer - may increase the ... 65, according to a new study. ,The study ... of men with prostate cancer. Although the findings need to ... oncologists should weigh the benefits of androgen deprivation therapy, or ...
    ... the HIV case in Libya involving five Bulgarian nurses and ... claimed that they were tortured brutally to give false testimonies. ... 1999 when they were accused of starting an HIV epidemic ... scientists, the infections have begun much before the arrival of ...
    ... the black soya bean-preventing// diabetes. ,The scientists from ... study in the Journal of Agricultural Food and Chemistry and ... when included in a daily diet can help prevent sugar ... soya hindering weight gain and lowering the levels of ...
    Cached Medicine News:Health News:Bhopal Gas Victims Demand Treatment of Children With Birth Defects 2Health News:Simple Model to Predict Chronic Kidney Disease 2Health News:Simple Model to Predict Chronic Kidney Disease 3Health News:Grossly Overweight Boy Likely to Be Sent into Care 2Health News:Prostate Cancer Therapy may Increase Risk of Death in Older Patients 2
    ... The use of guaiac as a test ... the oxidation of phenolic compounds present in guaiac ... blue color. If blood is present, the heme ... a pseudoenzymatic manner, catalyzing the release of oxygen ...
    ... The Original MaybeMom™ Mini Ovulation ... diagnostic instument which uses a ... personal menstrual/fertility cycle, including key ... and menstruation to increase her ...
    ... only test designed specifically for detecting ... pH. It includes a convenient pH ... range which is important in monitoring ... can now spend less time testing ...
    ... FSH Menopause Predictor Test is a ... detection of Follicle Stimulating Hormone (FSH) ... body hormone changes related to the ... menopause. The FHS Menopause Predictor ...
    Medicine Products: